Small Molecules
17 July 2017
Proclara Biosciences Announces Pipeline Progress12 July 2017
Viking Therapeutics Completes Enrollment in Phase 2 Study of VK5211 in Patients Recovering from Hip Fracture12 July 2017
U.S. FDA Confirms Amicus Therapeutics May Submit New Drug Application for Migalastat for Fabry Disease11 July 2017
ArQule Announces First Patient Dosed in Phase 1 Trial of BTK Inhibitor, ARQ 531, for B-cell Malignancies10 July 2017
Phenex AG announces milestone payment from Janssen for the entry of RORgt inhibitor into Phase I3 July 2017
U.S. New Drug Application for TREVYENT® for the Treatment of Pulmonary Arterial HypertensionNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports